In Vivo Measurement and Characterization of a Novel Formulation of [(177)Lu]-DOTA-Octreotate

OBJECTIVE(S): Lutetium-177 can be made with high specific activity and with no other isotopes of lutetium present, referred to as “No Carrier Added” (NCA) (177)Lu. We have radiolabelled DOTA-conjugated peptide DOTA-(Tyr(3))-octreotate with NCA (177)Lu (“NCA-LuTATE”) and used it in nearly 40 therapeu...

詳細記述

保存先:
書誌詳細
出版年:Asia Ocean J Nucl Med Biol
主要な著者: Bailey, Dale L, Hennessy, Thomas M, Willowson, Kathy P, Henry, E Courtney, Chan, David LH, Aslani, Alireza, Roach, Paul J
フォーマット: Artigo
言語:Inglês
出版事項: Asia Oceania Journal of Nuclear Medicine & Biology 2016
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937678/
https://ncbi.nlm.nih.gov/pubmed/27904871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7508/aojnmb.2016.04.005
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料